Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Roflumilast
Related studies linked through entity extraction aliases.
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE4
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- RECRUITING
- Phase
- PHASE1
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
- Status
- RECRUITING
- Phase
- PHASE3
Roflumilast and TMS Motor Plasticity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin
- Status
- RECRUITING
- Phase
- PHASE4
Efficacy of Roflumilast in Prevention of Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Roflumilast Versus Methotrexate in Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy
- Status
- COMPLETED
- Phase
- PHASE3
The Possible Effects of Roflumilast on Obesity Related Disorders
- Status
- COMPLETED
- Phase
- PHASE3
Possible Role of Roflumilast in Diabetic Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE3
Roflumilast as add-on Therapy in Early Cases of ARDS
- Status
- COMPLETED
- Phase
- PHASE2
Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy of Roflumilast in the Treatment of Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Roflumilast TMS-EEG Plasticity
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis
- Status
- COMPLETED
- Phase
- PHASE3
Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
- Status
- TERMINATED
- Phase
- PHASE1